Murphy, David

Link to this page

Authority KeyName Variants
orcid::0000-0003-2946-0353
  • Murphy, David (4)
Projects

Author's Bibliography

Evidence for involvement of central vasopressin V1b and V2 receptors in stress-induced baroreflex desensitization

Milutinović-Smiljanić, Sanja; Sarenac, Olivera; Lozic-Đurić, Maja; Murphy, David; Japundžić-Žigon, Nina

(Wiley-Blackwell, Hoboken, 2013)

TY  - JOUR
AU  - Milutinović-Smiljanić, Sanja
AU  - Sarenac, Olivera
AU  - Lozic-Đurić, Maja
AU  - Murphy, David
AU  - Japundžić-Žigon, Nina
PY  - 2013
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/1834
AB  - Background and Purpose It is well recognized that vasopressin modulates the neurogenic control of the circulation. Here, we report the central mechanisms by which vasopressin modulates cardiovascular response to stress induced by immobilization. Experimental Approach Experiments were performed in conscious male Wistar rats equipped with radiotelemetric device for continuous measurement of haemodynamic parameters: systolic and diastolic BP and heart rate (HR). The functioning of the spontaneous baro-receptor reflex (BRR) was evaluated using the sequence method and the following parameters were evaluated: BRR sensitivity (BRS) and BRR effectiveness index (BEI). Key Results Under baseline physiological conditions intracerebroventricular injection of 100 and 500ng of selective non-peptide V1a or V1b or V2 receptor antagonist did not modify BP, HR and BRR. Rats exposed to 15min long stress by immobilization exhibited increase of BP, HR, reduction of BRS and no change in BEI. Pretreatment of rats with V1a receptor antagonist did not modulate the BP, HR, BRS and BEI response to stress. Pretreatment of rats with V1b receptor and V2 receptor antagonist, at both doses, prevented BRR desensitization and tachycardia, but failed to modulate stress-induced hypertension. Conclusions and Implications Vasopressin by the stimulation of central V1b- and V2-like receptors mediates stress-induced tachycardia and BRR desensitization. If these mechanisms are involved, BRR desensitization in heart failure and hypertension associated with poor outcome, they could be considered as novel targets for cardiovascular drug development.
PB  - Wiley-Blackwell, Hoboken
T2  - British Journal of Pharmacology
T1  - Evidence for involvement of central vasopressin V1b and V2 receptors in stress-induced baroreflex desensitization
VL  - 169
IS  - 4
SP  - 900
EP  - 908
DO  - 10.1111/bph.12161
ER  - 
@article{
author = "Milutinović-Smiljanić, Sanja and Sarenac, Olivera and Lozic-Đurić, Maja and Murphy, David and Japundžić-Žigon, Nina",
year = "2013",
abstract = "Background and Purpose It is well recognized that vasopressin modulates the neurogenic control of the circulation. Here, we report the central mechanisms by which vasopressin modulates cardiovascular response to stress induced by immobilization. Experimental Approach Experiments were performed in conscious male Wistar rats equipped with radiotelemetric device for continuous measurement of haemodynamic parameters: systolic and diastolic BP and heart rate (HR). The functioning of the spontaneous baro-receptor reflex (BRR) was evaluated using the sequence method and the following parameters were evaluated: BRR sensitivity (BRS) and BRR effectiveness index (BEI). Key Results Under baseline physiological conditions intracerebroventricular injection of 100 and 500ng of selective non-peptide V1a or V1b or V2 receptor antagonist did not modify BP, HR and BRR. Rats exposed to 15min long stress by immobilization exhibited increase of BP, HR, reduction of BRS and no change in BEI. Pretreatment of rats with V1a receptor antagonist did not modulate the BP, HR, BRS and BEI response to stress. Pretreatment of rats with V1b receptor and V2 receptor antagonist, at both doses, prevented BRR desensitization and tachycardia, but failed to modulate stress-induced hypertension. Conclusions and Implications Vasopressin by the stimulation of central V1b- and V2-like receptors mediates stress-induced tachycardia and BRR desensitization. If these mechanisms are involved, BRR desensitization in heart failure and hypertension associated with poor outcome, they could be considered as novel targets for cardiovascular drug development.",
publisher = "Wiley-Blackwell, Hoboken",
journal = "British Journal of Pharmacology",
title = "Evidence for involvement of central vasopressin V1b and V2 receptors in stress-induced baroreflex desensitization",
volume = "169",
number = "4",
pages = "900-908",
doi = "10.1111/bph.12161"
}
Milutinović-Smiljanić, S., Sarenac, O., Lozic-Đurić, M., Murphy, D.,& Japundžić-Žigon, N.. (2013). Evidence for involvement of central vasopressin V1b and V2 receptors in stress-induced baroreflex desensitization. in British Journal of Pharmacology
Wiley-Blackwell, Hoboken., 169(4), 900-908.
https://doi.org/10.1111/bph.12161
Milutinović-Smiljanić S, Sarenac O, Lozic-Đurić M, Murphy D, Japundžić-Žigon N. Evidence for involvement of central vasopressin V1b and V2 receptors in stress-induced baroreflex desensitization. in British Journal of Pharmacology. 2013;169(4):900-908.
doi:10.1111/bph.12161 .
Milutinović-Smiljanić, Sanja, Sarenac, Olivera, Lozic-Đurić, Maja, Murphy, David, Japundžić-Žigon, Nina, "Evidence for involvement of central vasopressin V1b and V2 receptors in stress-induced baroreflex desensitization" in British Journal of Pharmacology, 169, no. 4 (2013):900-908,
https://doi.org/10.1111/bph.12161 . .
10
8
10

Blockade of central vasopressin receptors reduces the cardiovascular response to acute stress in freely moving rats

Stojičić, Sonja; Milutinović-Smiljanić, Sanja; Sarenac, Olivera; Milosavljević, S.; Paton, J. F. R.; Murphy, David; Japundžić-Žigon, Nina

(Pergamon-Elsevier Science Ltd, Oxford, 2008)

TY  - JOUR
AU  - Stojičić, Sonja
AU  - Milutinović-Smiljanić, Sanja
AU  - Sarenac, Olivera
AU  - Milosavljević, S.
AU  - Paton, J. F. R.
AU  - Murphy, David
AU  - Japundžić-Žigon, Nina
PY  - 2008
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/1431
AB  - To investigate the contribution of central vasopressin receptors to blood pressure (BP) and heart rate (HR) response to stress we injected non-peptide selective V-1a (SR49059), V-1b (SSR 149415), V-2 (SR 121463) receptor antagonists, diazepam or vehicle in the lateral cerebral ventricle of conscious freely moving rats stressed by blowing air on their heads for 2 min. Cardiovascular effects of stress were evaluated by analyzing maximum increase of BP and HR (MAX), latency of maximum response (LAT), integral under BP and HR curve (integral), duration of their recovery and spectral parameters of BP and HR indicative of increased sympathetic outflow (LFBP and LF/HFHR). Moreover, the increase of serum corticosterone was measured. Exposure to air-jet stress induced simultaneous increase in BP and HR followed by gradual decline during recovery while LFBP oscillation remained increased as well as serum corticosterone level. Rats pre-treated with vasopressin receptor antagonists were not sedated while diazepam induced sedation that persisted during exposure to stress. V-1a, V-1b and V-2, receptor antagonists applied separately did not modify basal values of cardiovascular parameters but prevented the increase in integral(BP). In addition, V-1b and V-2 receptor antagonists reduced BPMAX whereas V-1a, V-1b antagonist and diazepam reduced HRMAX induced by exposure to air-jet stress. All drugs shortened the recovery period, prevented the increase of LFBP without affecting the increase in serum corticosterone levels. Results indicate that vasopressin receptors located within the central nervous system mediate, in part, the cardiovascular response to air-jet stress without affecting either the neuroendocrine component or inducing sedation. They support the view that the V-1b receptor antagonist may be of potential therapeutic value in reducing arterial pressure induced by stress-related disorders.
PB  - Pergamon-Elsevier Science Ltd, Oxford
T2  - Neuropharmacology
T1  - Blockade of central vasopressin receptors reduces the cardiovascular response to acute stress in freely moving rats
VL  - 54
IS  - 5
SP  - 824
EP  - 836
DO  - 10.1016/j.neuropharm.2007.12.013
ER  - 
@article{
author = "Stojičić, Sonja and Milutinović-Smiljanić, Sanja and Sarenac, Olivera and Milosavljević, S. and Paton, J. F. R. and Murphy, David and Japundžić-Žigon, Nina",
year = "2008",
abstract = "To investigate the contribution of central vasopressin receptors to blood pressure (BP) and heart rate (HR) response to stress we injected non-peptide selective V-1a (SR49059), V-1b (SSR 149415), V-2 (SR 121463) receptor antagonists, diazepam or vehicle in the lateral cerebral ventricle of conscious freely moving rats stressed by blowing air on their heads for 2 min. Cardiovascular effects of stress were evaluated by analyzing maximum increase of BP and HR (MAX), latency of maximum response (LAT), integral under BP and HR curve (integral), duration of their recovery and spectral parameters of BP and HR indicative of increased sympathetic outflow (LFBP and LF/HFHR). Moreover, the increase of serum corticosterone was measured. Exposure to air-jet stress induced simultaneous increase in BP and HR followed by gradual decline during recovery while LFBP oscillation remained increased as well as serum corticosterone level. Rats pre-treated with vasopressin receptor antagonists were not sedated while diazepam induced sedation that persisted during exposure to stress. V-1a, V-1b and V-2, receptor antagonists applied separately did not modify basal values of cardiovascular parameters but prevented the increase in integral(BP). In addition, V-1b and V-2 receptor antagonists reduced BPMAX whereas V-1a, V-1b antagonist and diazepam reduced HRMAX induced by exposure to air-jet stress. All drugs shortened the recovery period, prevented the increase of LFBP without affecting the increase in serum corticosterone levels. Results indicate that vasopressin receptors located within the central nervous system mediate, in part, the cardiovascular response to air-jet stress without affecting either the neuroendocrine component or inducing sedation. They support the view that the V-1b receptor antagonist may be of potential therapeutic value in reducing arterial pressure induced by stress-related disorders.",
publisher = "Pergamon-Elsevier Science Ltd, Oxford",
journal = "Neuropharmacology",
title = "Blockade of central vasopressin receptors reduces the cardiovascular response to acute stress in freely moving rats",
volume = "54",
number = "5",
pages = "824-836",
doi = "10.1016/j.neuropharm.2007.12.013"
}
Stojičić, S., Milutinović-Smiljanić, S., Sarenac, O., Milosavljević, S., Paton, J. F. R., Murphy, D.,& Japundžić-Žigon, N.. (2008). Blockade of central vasopressin receptors reduces the cardiovascular response to acute stress in freely moving rats. in Neuropharmacology
Pergamon-Elsevier Science Ltd, Oxford., 54(5), 824-836.
https://doi.org/10.1016/j.neuropharm.2007.12.013
Stojičić S, Milutinović-Smiljanić S, Sarenac O, Milosavljević S, Paton JFR, Murphy D, Japundžić-Žigon N. Blockade of central vasopressin receptors reduces the cardiovascular response to acute stress in freely moving rats. in Neuropharmacology. 2008;54(5):824-836.
doi:10.1016/j.neuropharm.2007.12.013 .
Stojičić, Sonja, Milutinović-Smiljanić, Sanja, Sarenac, Olivera, Milosavljević, S., Paton, J. F. R., Murphy, David, Japundžić-Žigon, Nina, "Blockade of central vasopressin receptors reduces the cardiovascular response to acute stress in freely moving rats" in Neuropharmacology, 54, no. 5 (2008):824-836,
https://doi.org/10.1016/j.neuropharm.2007.12.013 . .
28
29
31

The role of central vasopressin receptors in the modulation of autonomic cardiovascular controls: a spectral analysis study

Milutinović-Smiljanić, Sanja; Murphy, David; Japundžić-Žigon, Nina

(Amer Physiological Soc, Bethesda, 2006)

TY  - JOUR
AU  - Milutinović-Smiljanić, Sanja
AU  - Murphy, David
AU  - Japundžić-Žigon, Nina
PY  - 2006
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/1319
AB  - Although it has been suggested that vasopressin (VP) acts within the central nervous system to modulate autonomic cardiovascular controls, the mechanisms involved are not understood. Using nonpeptide, selective V-1a, V-1b, and V-2 antagonists, in conscious rats, we assessed the roles of central VP receptors, under basal conditions, after the central application of exogenous VP, and after immobilization, on cardiovascular short-term variability. Equidistant sampling of blood pressure (BP) and heart rate (HR) at 20 Hz allowed direct spectral analysis in very-low frequency (VLF-BP), low-frequency (LF-BP), and high-frequency (HF-BP) blood pressure domains. The effect of VP antagonists and of exogenous VP on body temperature (T-b) was also investigated. Under basal conditions, V-1a antagonist increased HF-BP and T-b, and this was prevented by metamizol. V-1b antagonist enhanced HF-BP without affecting T-b, and V-2 antagonist increased VLF-BP variability which could be prevented by quinapril. Immobilization increased BP, LF-BP, HF-BP, and HF-HR variability. V-1a antagonist prevented BP and HR variability changes induced by immobilization and potentiated tachycardia. V-1b antagonist prevented BP but not HR variability changes, whereas V-2 antagonist had no effect. Exogenous VP increased systolic arterial pressure ( SAP) and HF-SAP variability, and this was prevented by V-1a and V-1b but not V-2 antagonist pretreatment. Our results suggest that, under basal conditions, VP, by stimulation of V-1a, V-1b, and cognate V-2 receptors, buffers BP variability, mostly due to thermoregulation. Immobilization and exogenous V-P, by stimulation of V-1a or V-1b, but not V-2 receptors, increases BP variability, revealing cardiorespiratory adjustment to stress and respiratory stimulation, respectively.
PB  - Amer Physiological Soc, Bethesda
T2  - American Journal of Physiology - Regulatory Integrative & Comparative Physiology
T1  - The role of central vasopressin receptors in the modulation of autonomic cardiovascular controls: a spectral analysis study
VL  - 291
IS  - 6
SP  - R1579
EP  - R1591
DO  - 10.1152/ajpregu.00764.2005
ER  - 
@article{
author = "Milutinović-Smiljanić, Sanja and Murphy, David and Japundžić-Žigon, Nina",
year = "2006",
abstract = "Although it has been suggested that vasopressin (VP) acts within the central nervous system to modulate autonomic cardiovascular controls, the mechanisms involved are not understood. Using nonpeptide, selective V-1a, V-1b, and V-2 antagonists, in conscious rats, we assessed the roles of central VP receptors, under basal conditions, after the central application of exogenous VP, and after immobilization, on cardiovascular short-term variability. Equidistant sampling of blood pressure (BP) and heart rate (HR) at 20 Hz allowed direct spectral analysis in very-low frequency (VLF-BP), low-frequency (LF-BP), and high-frequency (HF-BP) blood pressure domains. The effect of VP antagonists and of exogenous VP on body temperature (T-b) was also investigated. Under basal conditions, V-1a antagonist increased HF-BP and T-b, and this was prevented by metamizol. V-1b antagonist enhanced HF-BP without affecting T-b, and V-2 antagonist increased VLF-BP variability which could be prevented by quinapril. Immobilization increased BP, LF-BP, HF-BP, and HF-HR variability. V-1a antagonist prevented BP and HR variability changes induced by immobilization and potentiated tachycardia. V-1b antagonist prevented BP but not HR variability changes, whereas V-2 antagonist had no effect. Exogenous VP increased systolic arterial pressure ( SAP) and HF-SAP variability, and this was prevented by V-1a and V-1b but not V-2 antagonist pretreatment. Our results suggest that, under basal conditions, VP, by stimulation of V-1a, V-1b, and cognate V-2 receptors, buffers BP variability, mostly due to thermoregulation. Immobilization and exogenous V-P, by stimulation of V-1a or V-1b, but not V-2 receptors, increases BP variability, revealing cardiorespiratory adjustment to stress and respiratory stimulation, respectively.",
publisher = "Amer Physiological Soc, Bethesda",
journal = "American Journal of Physiology - Regulatory Integrative & Comparative Physiology",
title = "The role of central vasopressin receptors in the modulation of autonomic cardiovascular controls: a spectral analysis study",
volume = "291",
number = "6",
pages = "R1579-R1591",
doi = "10.1152/ajpregu.00764.2005"
}
Milutinović-Smiljanić, S., Murphy, D.,& Japundžić-Žigon, N.. (2006). The role of central vasopressin receptors in the modulation of autonomic cardiovascular controls: a spectral analysis study. in American Journal of Physiology - Regulatory Integrative & Comparative Physiology
Amer Physiological Soc, Bethesda., 291(6), R1579-R1591.
https://doi.org/10.1152/ajpregu.00764.2005
Milutinović-Smiljanić S, Murphy D, Japundžić-Žigon N. The role of central vasopressin receptors in the modulation of autonomic cardiovascular controls: a spectral analysis study. in American Journal of Physiology - Regulatory Integrative & Comparative Physiology. 2006;291(6):R1579-R1591.
doi:10.1152/ajpregu.00764.2005 .
Milutinović-Smiljanić, Sanja, Murphy, David, Japundžić-Žigon, Nina, "The role of central vasopressin receptors in the modulation of autonomic cardiovascular controls: a spectral analysis study" in American Journal of Physiology - Regulatory Integrative & Comparative Physiology, 291, no. 6 (2006):R1579-R1591,
https://doi.org/10.1152/ajpregu.00764.2005 . .
29
29
32

Central cholinergic modulation of blood pressure short-term variability

Milutinović-Smiljanić, Sanja; Murphy, David; Japundžić-Žigon, Nina

(Pergamon-Elsevier Science Ltd, Oxford, 2006)

TY  - JOUR
AU  - Milutinović-Smiljanić, Sanja
AU  - Murphy, David
AU  - Japundžić-Žigon, Nina
PY  - 2006
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/1307
AB  - The role of neurally born acetylcholine in the central modulation of cardiovascular short-term variability was assessed using a pharmacological probe physostigmine, a cholinesterase inhibitor that can act centrally also. Experiments were performed in instrumented conscious rats. Equidistant sampling at 20 Hz of systolic arterial pressure (SAP), diastolic arterial pressure (DAP) and heart rate (HR) allowed direct spectral analysis. Spectra were analysed in the whole, very-low frequency (VLF), low-frequency (LF) and high-frequency (HF) domains. Physostigmine, but not neostigmine, increased SAP, LF SAP and HF SAP variability while neostigmine, but not physostigmine, decreased HR without affecting HR variability. Atropine methyl nitrate prevented neostigmine-induced bradycardia and potentiated the effects of physostigmine on DAP, LF DAP and HF DAP variability. Atropine sulphate, hexamethonium, phentolamine and metoprolol inhibited physostigmine-induced increase of SAP and LF SAP. Pre-treatment of rats by quinapril prevented physostigmine-induced increase of SAP, but not of LF SAP, while the V-1a antagonist prevented the increase of HF SAP. The results suggest that central cholinergic neurons facilitate but do not create LF SAP and HF SAP variability. The effect of physostigmine on LF SAP seems to be mediated via central muscarinic sites and the peripheral sympathetic system, while non-muscarinic central sites and vasopressin pathways subserve the increase of HF SAP.
PB  - Pergamon-Elsevier Science Ltd, Oxford
T2  - Neuropharmacology
T1  - Central cholinergic modulation of blood pressure short-term variability
VL  - 50
IS  - 7
SP  - 874
EP  - 883
DO  - 10.1016/j.neuropharm.2005.12.009
ER  - 
@article{
author = "Milutinović-Smiljanić, Sanja and Murphy, David and Japundžić-Žigon, Nina",
year = "2006",
abstract = "The role of neurally born acetylcholine in the central modulation of cardiovascular short-term variability was assessed using a pharmacological probe physostigmine, a cholinesterase inhibitor that can act centrally also. Experiments were performed in instrumented conscious rats. Equidistant sampling at 20 Hz of systolic arterial pressure (SAP), diastolic arterial pressure (DAP) and heart rate (HR) allowed direct spectral analysis. Spectra were analysed in the whole, very-low frequency (VLF), low-frequency (LF) and high-frequency (HF) domains. Physostigmine, but not neostigmine, increased SAP, LF SAP and HF SAP variability while neostigmine, but not physostigmine, decreased HR without affecting HR variability. Atropine methyl nitrate prevented neostigmine-induced bradycardia and potentiated the effects of physostigmine on DAP, LF DAP and HF DAP variability. Atropine sulphate, hexamethonium, phentolamine and metoprolol inhibited physostigmine-induced increase of SAP and LF SAP. Pre-treatment of rats by quinapril prevented physostigmine-induced increase of SAP, but not of LF SAP, while the V-1a antagonist prevented the increase of HF SAP. The results suggest that central cholinergic neurons facilitate but do not create LF SAP and HF SAP variability. The effect of physostigmine on LF SAP seems to be mediated via central muscarinic sites and the peripheral sympathetic system, while non-muscarinic central sites and vasopressin pathways subserve the increase of HF SAP.",
publisher = "Pergamon-Elsevier Science Ltd, Oxford",
journal = "Neuropharmacology",
title = "Central cholinergic modulation of blood pressure short-term variability",
volume = "50",
number = "7",
pages = "874-883",
doi = "10.1016/j.neuropharm.2005.12.009"
}
Milutinović-Smiljanić, S., Murphy, D.,& Japundžić-Žigon, N.. (2006). Central cholinergic modulation of blood pressure short-term variability. in Neuropharmacology
Pergamon-Elsevier Science Ltd, Oxford., 50(7), 874-883.
https://doi.org/10.1016/j.neuropharm.2005.12.009
Milutinović-Smiljanić S, Murphy D, Japundžić-Žigon N. Central cholinergic modulation of blood pressure short-term variability. in Neuropharmacology. 2006;50(7):874-883.
doi:10.1016/j.neuropharm.2005.12.009 .
Milutinović-Smiljanić, Sanja, Murphy, David, Japundžić-Žigon, Nina, "Central cholinergic modulation of blood pressure short-term variability" in Neuropharmacology, 50, no. 7 (2006):874-883,
https://doi.org/10.1016/j.neuropharm.2005.12.009 . .
15
11
16